Seggern Christopher Von's most recent trade in Xenon Pharmaceuticals Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc | Seggern Christopher Von | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Xenon Pharmaceuticals Inc | Seggern Christopher Von | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
Xenon Pharmaceuticals Inc | Seggern Christopher Von | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Xenon Pharmaceuticals Inc | Seggern Christopher Von | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Xenon Pharmaceuticals Inc | Seggern Christopher Von | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |